Literature DB >> 14531744

Inflammatory bowel disease.

M R B Keighley1, R W Stockbrugger.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14531744     DOI： 10.1046/j.0953-0673.2003.01727.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  10 in total

Review 1.  New molecular insights into inflammatory bowel disease-induced diarrhea.

Authors:  Yueming Tang; Christopher B Forsyth; Ali Keshavarzian
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2011-10       Impact factor: 3.869

Review 2.  Getting personal: a review of sexual functioning, body image, and their impact on quality of life in patients with inflammatory bowel disease.

Authors:  Sharon Jedel; Megan M Hood; Ali Keshavarzian
Journal:  Inflamm Bowel Dis       Date:  2015-04       Impact factor: 5.325

3.  Selective effect of infliximab on the inflammatory component of a colonic stricture in Crohn's disease.

Authors:  Dario Sorrentino; Claudio Avellini; Carlo Alberto Beltrami; Enrico Pasqual; Ester Zearo
Journal:  Int J Colorectal Dis       Date:  2005-06-11       Impact factor: 2.571

4.  Epidemiological characteristics of inflammatory bowel disease in North-Eastern Poland.

Authors:  Alicja Wiercinska-Drapalo; Jerzy Jaroszewicz; Robert Flisiak; Danuta Prokopowicz
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

5.  Osthole pretreatment alleviates TNBS-induced colitis in mice via both cAMP/PKA-dependent and independent pathways.

Authors:  Wu Sun; Yun Cai; Xin-Xin Zhang; Hao Chen; Yan-Die Lin; Hao Li
Journal:  Acta Pharmacol Sin       Date:  2017-06-12       Impact factor: 6.150

6.  A randomized controlled trial of mindfulness-based stress reduction to prevent flare-up in patients with inactive ulcerative colitis.

Authors:  S Jedel; A Hoffman; P Merriman; B Swanson; R Voigt; K B Rajan; M Shaikh; H Li; A Keshavarzian
Journal:  Digestion       Date:  2014-02-14       Impact factor: 3.216

7.  Sleep deprivation worsens inflammation and delays recovery in a mouse model of colitis.

Authors:  Yueming Tang; Fabian Preuss; Fred W Turek; Shriram Jakate; Ali Keshavarzian
Journal:  Sleep Med       Date:  2009-04-28       Impact factor: 3.492

8.  Mindfulness-based cognitive therapy for inflammatory bowel disease patients: findings from an exploratory pilot randomised controlled trial.

Authors:  Mariyana Schoultz; Iain Atherton; Angus Watson
Journal:  Trials       Date:  2015-08-25       Impact factor: 2.279

9.  Participants' perspectives on mindfulness-based cognitive therapy for inflammatory bowel disease: a qualitative study nested within a pilot randomised controlled trial.

Authors:  Mariyana Schoultz; Leah Macaden; Gill Hubbard
Journal:  Pilot Feasibility Stud       Date:  2016-01-19

10.  Farrerol Ameliorates TNBS-Induced Colonic Inflammation by Inhibiting ERK1/2, JNK1/2, and NF-κB Signaling Pathway.

Authors:  Xin Ran; Yuhang Li; Guangxin Chen; Shoupeng Fu; Dewei He; Bingxu Huang; Libin Wei; Yuanqing Lin; Yingcheng Guo; Guiqiu Hu
Journal:  Int J Mol Sci       Date:  2018-07-13       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.